Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC).

Christine Nichols,Sandra A. Mitchell,K. Lang,Victoria Federico,Kathleen Castro,Lauren J. Rogak,Deepa Lalla,Steven B. Clauser,Bryce B. Reeve,Andrea Denicoff,Alice P. Chen,Richard Piekarz,Thomas M. Atkinson,Musa Mayer,Melissa Brammer,Laura Sit,Ann M. O’Mara,Lori M. Minasian,Ethan Basch

Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC).

2017

Christine Nichols
Sandra A. Mitchell
K. Lang
Victoria Federico
Kathleen Castro
Lauren J. Rogak
Deepa Lalla
Steven B. Clauser
Bryce B. Reeve
Andrea Denicoff
Alice P. Chen
Richard Piekarz
Thomas M. Atkinson
Musa Mayer
Melissa Brammer
Laura Sit
Ann M. O’Mara
Lori M. Minasian
Ethan Basch

e19633 Background: NCI PRO-CTCAE is a new patient-reported outcome measure designed to enhance adverse event (AE) reporting in clinical trials by integrating the patient experience. The PRO-CTCAE i...

Keywords:

Physical therapy
Clinical trial
Common Terminology Criteria for Adverse Events
Metastatic breast cancer
Internal medicine
Patient experience
Medicine
Adverse effect
pro ctcae
outcome measures

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations